browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
6c888568-8523-43d7-9110-c121df645c8d
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 23:23:07
Income (reported)
$80,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

CGCN GROUP, LLC

Public Affairs Consultants

Contact
STEVE CLARK
Phone
+1 202-628-0028
Address
zip:20005, city:Washington, state:DC, street:1307 New York Ave., NW Suite 600
Client

VERTEX PHARMACEUTICALS INCORPORATED

Biopharmaceutical Company

State
MA
Country
US
Effective date
2024-12-06
Issues lobbied + lobbyists (2)

HCR — Health Issues

Access to innovative non-opioid medicines.

Lobbyists:

Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office

MMM — Medicare/Medicaid

Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.